Stocks
Novozymes A/SNVZMY
OTCBasic MaterialsSpecialty Chemicals$54.51-0.04%
Price as of · delayed, not real-time
A global leader in biological solutions, this company specializes in enzyme and microbial technologies for industries ranging from agriculture to household care. Investors monitor its performance due to its dominant position in bioinnovation and sustainability-driven product lines.
Market Cap: $25.6B52W Range: $53.50 – $75.99
Congressional Interest in Novozymes A/S (NVZMY)
4 members of Congress have disclosed 14 trades in Novozymes A/S (NVZMY), a Basic Materials company. The buy/sell breakdown shows 8 purchases versus 6 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
4
Buys
8
Sells
6
Who in Congress Is Trading NVZMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-10-16 | Josh Gottheimer | buy | $1K – $15K |
| 2023-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2021-02-17 | Peter Meijer | sell | $1K – $15K |
| 2020-08-04 | Greg Gianforte | sell | $15K – $50K |
| 2020-03-18 | Greg Gianforte | buy | $1K – $15K |
| 2020-01-13 | Greg Gianforte | buy | $15K – $50K |
| 2019-10-11 | Greg Gianforte | buy | $50K – $100K |
| 2019-09-10 | Greg Gianforte | sell | $100K – $250K |
| 2019-06-24 | Donna Shalala | sell | $1K – $15K |
| 2018-12-21 | Greg Gianforte | buy | $100K – $250K |
| 2018-11-20 | Greg Gianforte | sell | $100K – $250K |
| 2018-10-11 | Josh Gottheimer | buy | $1K – $15K |
| 2018-03-20 | Greg Gianforte | buy | $100K – $250K |
| 2018-03-16 | Josh Gottheimer | buy | $1K – $15K |